Skip to main content
Translational Psychiatry logoLink to Translational Psychiatry
. 2019 Aug 5;9:186. doi: 10.1038/s41398-019-0520-8

Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study

Yansong Li 1,2,✉,#, Zixiang Wang 1,2,#, Isabelle Boileau 3, Jean-Claude Dreher 4, Sofie Gelskov 5, Alexander Genauck 6, Juho Joutsa 7, Valtteri Kaasinen 7, José C Perales 8, Nina Romanczuk-Seiferth 6, Cristian M Ruiz de Lara 8, Hartwig R Siebner 5,9, Ruth J van Holst 10, Tim van Timmeren 10, Guillaume Sescousse 11,
PMCID: PMC6683128  PMID: 31383841

Abstract

Gambling disorder is a serious psychiatric condition characterized by decision-making and reward processing impairments that are associated with dysfunctional brain activity in the orbitofrontal cortex (OFC). However, it remains unclear whether OFC functional abnormalities in gambling disorder are accompanied by structural abnormalities. We addressed this question by examining the organization of sulci and gyri in the OFC. This organization is in place very early and stable across life, such that OFC sulcogyral patterns (classified into Types I, II, and III) can be regarded as potential pre-morbid markers of pathological conditions. We gathered structural brain data from nine existing studies, reaching a total of 165 individuals with gambling disorder and 159 healthy controls. Our results, supported by both frequentist and Bayesian statistics, show that the distribution of OFC sulcogyral patterns is skewed in individuals with gambling disorder, with an increased prevalence of Type II pattern compared with healthy controls. Examination of gambling severity did not reveal any significant relationship between OFC sulcogyral patterns and disease severity. Altogether, our results provide evidence for a skewed distribution of OFC sulcogyral patterns in gambling disorder and suggest that pattern Type II might represent a pre-morbid structural brain marker of the disease. It will be important to investigate more closely the functional implications of these structural abnormalities in future work.

Subject terms: Addiction, Human behaviour

Introduction

Gambling disorder, from here onwards referred to as pathological gambling1, is a behavioral addiction with severe consequences, including bankruptcy, relationship problems, and suicide1. Consistent with the idea that psychiatric disorders have a biological basis in the brain2, functional neuroimaging studies have revealed a core network of dysfunctional brain regions in individuals suffering from pathological gambling3. Central to this network is the orbitofrontal cortex (OFC), which displays abnormal activity across a number of cognitive tasks, including expected reward valuation4,5, monetary reward processing68, risky decision-making9,10, and conflict monitoring11. However, it remains unclear whether this alteration in OFC brain function reflects underlying structural abnormalities.

There is a large body of research suggesting that individual variability in brain function is closely related to individual variability in brain structure12. Using magnetic resonance imaging, most studies have focused on gray matter volume and cortical thickness as meaningful sources of structural variability. While a few studies have reported decreased OFC gray matter volume1315 and decreased cortical thickness16 in pathological gamblers (PGs) compared with healthy controls (HCs), other studies have failed to report significant group differences1720. These inconsistencies might reflect the influence of factors such as age, comorbidities, and head motion acting as confounds on structural brain measures21, as well as the heterogeneity existing among gamblers, as suggested by a recent study that found decreased OFC gray matter volume specifically in gamblers showing low risk-taking22. As a matter of fact, structural abnormalities observed in PGs are less consistent and of more modest magnitude than those reported in substance addiction19,20,23. Moreover, it is unclear whether these structural abnormalities represent a pre-morbid marker or are a mere consequence of the disease, as observed in other disorders24,25. One way to address this question is to examine the sulcogyral organization of the OFC.

The organization of sulci and gyri in the brain is governed by cortical folding, which occurs in the perinatal period and leads to sulcogyral patterns that are stable across life26,27. As such, these patterns can be regarded as reliable structural traits that provide an opportunity to investigate possible pre-morbid markers of psychiatric disorders, independently of confounding factors such as illness duration or medication use28. In the OFC, sulcogyral patterns have been classified into three different types (Types I, II, and III) based on the continuity/discontinuity of the medial and lateral orbitofrontal sulci29 (see Fig. 1 and “Materials and methods” for details). In previous work, we have observed that sulcogyral pattern types constrain the location of reward-related value signals in the OFC30. In the field of psychiatry, the impact of OFC sulcogyral patterns has been studied extensively in the context of schizophrenia. Nakamura et al.31 initially reported a decreased proportion of Type I pattern and an increased proportion of Type II and III patterns in individuals suffering from schizophrenia. These findings have been replicated in further studies3237 and extended to individuals at high risk of developing schizophrenia38,39 (but see ref. 40), suggesting that Types II and III might represent pre-morbid markers of schizophrenia. Among patients with schizophrenia, Type III in particular has been associated with poorer cognitive functioning and intelligence quotient (IQ), as well as more severe symptoms and impulsivity31,37,40. However, very little work has been done outside of schizophrenia. While one study reported an increased prevalence of Type III in autism spectrum disorders41, another study showed that Type III was associated with greater lifetime cannabis consumption in cannabis users42.

Fig. 1. Classification of the orbitofrontal cortex sulcogyral patterns with magnetic resonance imaging.

Fig. 1

Examples of the four major sulcogyral patterns from four different participants. Patterns were classified into four subtypes (Types I–IV) according to the continuity of the lateral and medial orbital sulci (LOS and MOS, respectively) in the rostrocaudal direction (r rostral, c caudal). Type I refers to continuous LOS and discontinuous MOS (a), Type II refers to continuous LOS and MOS (b), Type III refers to discontinuous LOS and MOS (c), and Type IV refers to continuous MOS and discontinuous LOS (d). Sulcal continuities of the MOS and LOS were determined by evaluating several consecutive axial slices rather than just a single slice. TOS transverse orbital sulcus

In this study, we aimed to examine the distribution of OFC sulcogyral patterns among PGs, as well as their relationship with gambling severity, under the premise that the well-described functional impairments reported in the OFC might reflect pre-morbid structural markers. In order to maximize statistical power, we pooled together nine existing structural magnetic resonance imaging (MRI) datasets. Because we found it hazardous to make predictions based on the existing literature, we refrained from making specific hypotheses and consider this study to be exploratory.

Materials and methods

Participants

A total of 177 PGs and 169 HCs were included in the present study. These data were pooled from nine separate previous neuroimaging studies8,15,18,4348 (Supplementary Table 1). From this aggregated sample, 18 participants (10 PGs and 8 HCs) were excluded because of head movement artifacts on anatomical T1 scans preventing us from reliably identifying OFC sulcogyral patterns, and 4 participants (2 PGs and 2 HCs) were excluded because either demographic or diagnostic information was missing. As a result, 165 PGs (164 men/1 woman, age = 34.25 ± 10.00 years) and 159 HCs (154 men/5 women, age = 33.00 ± 9.76 years) were included in the final analysis. The two groups were matched on age, gender, and handedness within individual studies, which was verified at the whole-population level (Table 1). In addition, all individual studies matched the groups on IQ and/or education level, while seven out of nine studies matched the groups on the number of smokers. All participants gave written informed consent to be part of the original studies, which were approved by the local ethics committees.

Table 1.

Demographic and clinical characteristics of the sample (pooled across nine studies)

PGs (N = 165) HCs (N = 159) Group comparison
Age 34.25 ± 10.00 33.00 ± 9.76 t(322) = 1.14, p = 0.257
Gender (M/F) 164/1 154/5 χ2 = 1.64, p = 0.200
Handedness (R/L/mixed) 152/11/2 149/4/6 p = 0.080 (FET)
SOGS 10.30 ± 4.14 (N = 148) 0.41 ± 0.88 (N = 144) t(160.64) = 28.42, p < 0.001
PG-YBOCS 24.35 ± 7.06 (N = 17) 10.87 ± 1.69 (N = 15) t(18.05) = 7.63, p < 0.001

For age, SOGS, and PG-YBOCS, numbers represent mean ± standard deviation

FET Fisher’s exact test, SOGS South Oaks Gambling Screen, F female, M male, PG-YBOCS Yale Brown Obsessive Compulsive Scale adapted for Pathological Gambling, PG pathological gambler, HC healthy control

The PGs of all nine studies were diagnosed using psychiatric interviews or questionnaires based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria. Furthermore, eight of these studies used the South Oaks Gambling Screen questionnaire (SOGS)49 to assess the severity of gambling symptoms, while the last one used the Yale Brown Obsessive Compulsive Scale adapted for Pathological Gambling (PG-YBOCS)50 (Table 1). None of the HCs had a known history of neurological disorder or current psychiatric Axis I disorder, except for one of them meeting past criteria for alcohol abuse. In the gambling group, given the high comorbidity between pathological gambling and other psychiatric disorders51, gamblers with the following comorbidities were included: current cannabis dependence (N = 1), past cannabis dependence (N = 1), past cannabis abuse (N = 1), past alcohol dependence (N = 2), past alcohol abuse (N = 1), lifetime history of dysthymia (N = 1), remitted post-traumatic stress disorder (N = 2). In addition, three gamblers used cannabis weekly in the past 6 months before scanning but did not meet the DSM-IV criteria for abuse/dependence.

MRI acquisition

T1-weighted structural MR images were independently acquired at each imaging site. Data acquisition details are summarized in Supplementary Table 1 based on the descriptions from the original studies.

OFC sulcogyral pattern classification

The procedures for classifying the OFC sulcogyral patterns in this study were based on one of our previous studies30. Specifically, the OFC sulcogyral patterns were identified separately in each hemisphere using the medical image analysis software MRIcro (https://people.cas.sc.edu/rorden/mricro/index.html) and classified according to the criteria described by Chiavaras and Petrides29. With regard to the orbitofrontal sulci in the human brain, four main sulci have been identified, namely, the olfactory, medial, lateral, and transverse orbital sulci. On the basis of the continuity of the medial and lateral orbital sulci (MOS and LOS, respectively), the original work by Chiavaras and Petrides29 classified the morphology of the human orbitofrontal sulci into three main types in each hemisphere (Type I, II, and III), while a fourth type (Type IV) was later identified in a number of studies36,38,40,41 (Fig. 1). In Type I, rostral and caudal portions of the LOS (LOSr and LOSc, respectively) are connected to one another, whereas the rostral and caudal portions of the MOS (MOSr and MOSc, respectively) are clearly separate (Fig. 1a). Compared with the Type I pattern, the distinctive feature of the Type II is that rostral portions of both LOS and MOS are connected to their caudal portions, forming the continuous MOS and LOS, and both sulci are jointed by the horizontally oriented transverse orbital sulcus (Fig. 1b). In Type III, the critical distinctive characteristic is that the rostral and caudal parts of both MOS and LOS are clearly disconnected (Fig. 1c). In Type IV, LOSr and LOSc are interrupted in the presence of a continuous MOS, thus representing the opposite of Type I (Fig. 1d). The sulcus continuity was determined by evaluating several adjacent axial slices rather than focusing on one single slice.

Two raters (Y.L. and Z.W.), who were blind to the participants’ identity, independently performed the OFC sulcogyral pattern classification for all participants. Inter-rater reliability (Cohen’s kappa) was 0.84 for the left hemisphere and 0.83 for the right hemisphere. All ambiguous classifications identified in the current sample (i.e., 9% of the total sample) were reviewed by Y.L. and consensus was reached.

Statistical analyses

All analyses were performed using SPSS for frequentist statistics (http://www.spss.com/software) and JASP for Bayesian statistics (https://jasp-stats.org). Independent-samples two-sided t tests (with correction for inhomogeneity of variance where appropriate) were performed to assess group differences in age, SOGS, and PG-YBOCS. Pearson’s χ2 test, or Fisher’s exact test (when >20% of cells had expected counts <5) were employed to evaluate group differences in gender and handedness.

Group differences in OFC sulcogyral patterns were evaluated using frequentist χ2 tests (producing p values) and Bayesian contingency table analyses (producing Bayes Factors (BFs)) on the distribution of Type I, Type II, and Type III patterns. Because hemispheres with a Type IV pattern were rare (4% of all hemispheres), they were excluded from the statistical analyses, in line with the procedure used in a number of previous studies36,38,40,41. These analyses were performed across the left and right hemispheres, as well as separately in each hemisphere. To further identify which OFC sulcogyral types have a skewed frequency in PGs compared with HCs, post hoc χ2 tests were performed for each sulcogyral pattern separately. Since the latter pairwise analysis involves three comparisons (Type I, II, and III), we used a Bonferroni-corrected threshold of 0.05/3 = 0.017. In order to verify that the OFC sulcogyral pattern distribution in HCs was comparable to that reported in the reference study of Chiavaras and Petrides29, we also compared these distributions statistically using the same tests as above. Finally, we used a categorical regression analysis to examine whether sulcogyral pattern types were associated with clinical symptoms (SOGS scores) in PGs. This latter analysis was performed on N = 148 PGs (instead of the full sample N = 165 PGs) since one of the studies45 did not report SOGS scores. Following the approach used in previous studies31,37,41, we defined three categorical predictors corresponding to the three main sulcogyral patterns (Types I, II, and III). For each predictor and each participant, we assigned a value of two if the sulcogyral pattern under consideration was present in either hemisphere (i.e., in the left, right, or both hemispheres), and a value of one if the sulcogyral pattern was absent in either hemisphere. We report the overall fit as well as the standardized coefficients for each predictor.

Results

Group differences in orbitofrontal sulcogyral patterns

Table 2 and Fig. 2 illustrate the OFC sulcogyral pattern distribution observed in each group (detailed distributions for each study are provided in Supplementary Tables 2 and 3). Importantly, the sulcogyral pattern distribution observed in HCs was very close to that reported in the original study of Chiavaras and Petrides29 (Left hemisphere: χ2 = 0.02, p = 0.991, BF10 = 0.139; Right hemisphere: χ2 = 2.25, p = 0.324, BF10 = 0.347; All hemispheres: χ2 = 0.62, p = 0.734, BF10 = 0.173). This indicates that any group difference in the present study is more likely to result from an unusual distribution in the gambling group rather than in the healthy group. In addition, and in line with the results from Nakamura et al.31, we did not find evidence supporting a relationship between the OFC sulcogyral patterns present in left and right hemispheres, as revealed by likelihood ratio (LR) tests in multinomial logistic regressions (HCs: LRχ2 = 3.32, p = 0.51; PGs: LRχ2 = 8.81, p = 0.08; detailed distributions of OFC sulcogyral patterns as a function of left–right combination are reported in Supplementary Table 4). We thus treated hemispheres as independent and pooled them together in some of the subsequent analyses.

Table 2.

Distribution of OFC sulcogyral patterns

PGs (N = 165) HCs (N = 159) HCs from Chiavaras and Petridesb χ2 p Value BF10
N (%) N (%) N (%)
Left hemispherea 5.29 0.071 1.17
 Type I 65 (39) 74 (47) 24 (48) 1.49 0.223 0.58
 Type II 76 (46) 55 (34) 17 (34) 4.88 0.027 3.12
 Type III 19 (12) 27 (17) 9 (18) 1.87 0.171 0.50
 Type IV 5 (3) 3 (2) 0 (0)
Right hemispherea 4.85 0.088 0.82
 Type I 75 (45) 84 (53) 32 (64) 1.39 0.238 0.56
 Type II 72 (44) 53 (33) 13 (26) 4.19 0.041 2.19
 Type III 13 (8) 20 (13) 5 (10) 1.81 0.179 0.41
 Type IV 5 (3) 2 (1) 0 (0)
Total (L+R)a 10.11 0.006 6.29
 Type I 140 (42) 158 (50) 56 (56) 2.88 0.090 0.83
 Type II 148 (45) 108 (34) 30 (30) 9.06 0.003 18.0
 Type III 32 (10) 47 (15) 14 (14) 3.65 0.056 0.80
 Type IV 10 (3) 5 (1) 0 (0)

Because pairwise group comparison analyses involved three statistical tests (one per OFC subtype), we used a Bonferroni-corrected significance threshold of 0.05/3 = 0.017

Statistically significant results (i.e. p < 0.017) are displayed in bold

PGs pathological gamblers, HCs healthy controls, BF Bayes Factor, L left, R right

aAnalyses comparing the distribution of OFC sulcogyral patterns between PGs and HCs in the present study

bData from the HCs (N = 50) of Chiavaras and Petrides (2000) are included in the table for ease of comparison

Fig. 2. Distribution of the orbitofrontal cortex sulcogyral patterns in the left hemisphere, right hemisphere, and across both hemispheres, in both pathological gamblers (N = 165) and healthy controls (N = 159).

Fig. 2

**p < 0.005

Across the left and right hemispheres, a χ2 analysis revealed that the OFC sulcogyral pattern distribution in PGs was significantly different from that observed in HCs (χ2 = 10.11, Cramer’s V = 0.126, p = 0.006). In order to quantify the evidence in favor of a group difference, we performed a Bayesian contingency table analysis based on a Poisson sampling model52, using the default uniform priors implemented in JASP. The resulting BF (BF10 = 6.29) indicated that our data were about 6 times more likely under the hypothesis of a group difference than under the null hypothesis of no group difference. Such a BF is traditionally interpreted as moderate evidence for the alternative hypothesis that there is indeed an association between the group and OFC sulcogyral pattern distribution. Post hoc tests further showed that the group difference was primarily driven by a significantly enhanced prevalence of Type II pattern in PGs compared with HCs (45% vs 34%, χ2 = 9.06, Cramer’s V = 0.120, p = 0.003). The associated BF (BF10 = 18.0) confirmed this result, indicating strong evidence for a different proportion of Type II pattern between PGs and HCs. In contrast, we found no significant difference in the distribution of Type I (χ2 = 2.88, p = 0.090, BF10 = 0.83) and Type III (χ2 = 3.65, p = 0.056, BF10 = 0.80) patterns. Also, when examining the left and right hemispheres separately, the group difference in OFC sulcogyral pattern distribution did not reach significance (left: χ2 = 5.29, p = 0.071, BF10 = 1.17: right: χ2 = 4.85, p = 0.088, BF10 = 0.82). Note though that the distribution of OFC sulcogyral patterns was very similar between the left and right hemispheres in both HCs (χ2 = 1.71, p = 0.425, BF10 = 0.20) and PGs (χ2 = 1.95, p = 0.378, BF10 = 0.19).

With regards to left/right hemisphere combinations, 22.4% of PGs (compared with 12.6% of HCs) had a Type II pattern in both hemispheres (χ2 = 5.41, Cramer’s V = 0.129, p = 0.020; BF10 = 3.12). Furthermore, 67.3% of PGs (compared with 55.3% of HCs) had at least one hemisphere with a Type II pattern (χ2 = 4.86, Cramer’s V = 0.122, p = 0.027; BF10 = 3.01). In terms of relative risk, participants with a Type II pattern in both hemispheres had a 1.35-fold increased risk of being in the gambling group, compared with participants who had only one or zero Type II pattern in either hemisphere. Similarly, participants with at least one hemisphere with a Type II pattern had a 1.29-fold increased risk of being in the gambling group, compared with participants without any Type II pattern.

OFC sulcogyral patterns and clinical measures

The categorical regression analysis revealed no significant relationship between OFC sulcogyral pattern types and total SOGS scores in PGs (Overall fit: F(3,144) = 0.10, p = 0.963 – Standardized coefficients: βTypeI = −0.03, F = 0.08, p = 0.779; βTypeII = −0.05, F = 0.27, p = 0.600; βTypeIII = −0.02, F = 0.06, p = 0.810).

Discussion

This study is the first to investigate the distribution of OFC sulcogyral patterns in pathological gambling, and more broadly, in addiction. Our results, supported by both frequentist and Bayesian statistics, show that the distribution of OFC sulcogyral patterns is skewed in PGs, with the Type II pattern showing a moderate increase in prevalence compared with HCs. The presence of a Type II pattern was not associated with higher gambling severity. Altogether, these results suggest that Type II pattern might represent a pre-morbid structural brain marker of pathological gambling but without predictive value for symptom severity.

The finding of a skewed distribution of OFC sulcogyral patterns in pathological gambling is of potential clinical relevance, especially given the lack of reliable neuroanatomical markers for this pathology. It also strengthens the existing evidence supporting a central role for the OFC in pathological gambling3. Given that sulcogyral patterns are in place very early during brain development and are stable across the lifespan26,27, our results also support the idea that pathological gambling has a partly neurodevelopmental origin. This idea resonates with the results of previous studies on substance abuse, showing that pre-existing structural traits in the OFC have predictive value for later substance use in adolescents53,54. In particular, Kühn et al.55 have shown that lower gyrification in the OFC, presumably related to prenatal alcohol exposure, was associated with increased alcohol-related problems in the next 2 years. Similarly, Chye et al.42 have found that cannabis users with OFC sulcogyral pattern Type III consumed more cannabis over their lifetime. Together, these results support the hypothesis that neurodevelopmental structural traits in the OFC might predispose to addictive behaviors.

From a mechanistic perspective, the key question is how individual differences in OFC sulcogyral patterns would influence the vulnerability to develop (gambling) addictive behaviors. One idea is that this may be mediated through individual differences in OFC connectivity. Indeed, cortical folding patterns are constrained by white matter tracts, such as the uncinate fasciculus that connects the OFC to the anterior temporal lobe within the limbic system56, and are thus thought to reflect structural57,58 as well as functional connectivity59. Thus the skewed distribution of OFC sulcogyral patterns in PGs may reflect altered connectivity patterns, which may in turn affect important cognitive functions of the OFC such as decision-making or behavioral inhibition. Altered OFC sulcogyral patterns and associated changes in OFC connectivity might also be associated with certain personality traits known to predispose to addictive behaviors. In particular, Type II pattern has been associated with positive emotionality31 and increased physical anhedonia60 in healthy individuals. These seemingly opposite personality traits are key defining features of two subtypes of gamblers known as “antisocial-impulsive” and “emotionally vulnerable”, respectively61. Thus, it could be that the increased prevalence of OFC sulcogyral Type II pattern among PGs in the present study reflects the increased prevalence of positive emotionality and anhedonic traits among these two subpopulations. Interestingly, in healthy individuals, Type III pattern has also been associated with improved regulatory control31, a trait known to be protective against addictive behaviors. This would be consistent with a trend toward a lower prevalence of Type III pattern among gamblers compared with HCs in the present study (although the differences did not reach significance). Future studies should explicitly test these hypotheses.

This study has various strengths. The sample size was larger than in any previous structural imaging study on pathological gambling and was larger than in most previous studies investigating OFC sulcogyral patterns in psychiatric disorders. The OFC sulcogyral pattern classification was performed independently by two raters for all participants, thus reducing the chances of misclassification. We also used a combination of frequentist and Bayesian statistics and applied stringent Bonferroni correction for multiple comparisons where appropriate.

This study also has some limitations. First, the interpretation of our structural brain results in terms of functional consequences is limited by the fact that we did not have functional assessments at hand, such as behavioral scores, questionnaires, or brain activity measures. In particular, we were not able to distinguish between different subtypes of gamblers, while these subtypes may be associated with different brain abnormalities as suggested above. This is the main drawback of our strategy to increase statistical power by pooling together datasets from different studies, since the functional assessments did not overlap between these studies. Future work needs to elucidate the link between OFC sulcogyral patterns and their functional implications. Furthermore, the effect sizes we found are relatively small (Cramer’s V between 0.12 and 0.13), suggesting that the observed increased prevalence of Type II pattern is a relatively subtle effect that only affects a minority of gamblers. This might explain why the group difference in OFC sulcogyral pattern type distribution did not reach significance when examined in each hemisphere separately, even though these distributions were qualitatively very similar to the one seen across both hemispheres combined. Finally, we did not find a relationship between OFC sulcogyral patterns and gambling severity. While this might sound surprising, several studies that have reported skewed distribution of OFC sulcogyral patterns in schizophrenia similarly did not observe significant relationships with symptom severity32,34. As suggested by these studies, it could be that OFC sulcogyral patterns do not affect disease progression or affect it only in the later course of the disease.

In conclusion, our results provide evidence for a skewed distribution of OFC sulcogyral patterns in pathological gambling in a large cohort of individuals studied across different neuroimaging centers. Since this was an exploratory study, it will be very important to replicate this result in an independent sample. Also, based on previous reports of gender differences in the distribution of OFC sulcogyral patterns in other disorders such as schizophrenia35,37, it will be important to test whether our results—observed in an almost entirely male sample—are generalizable to a female gambling population. Finally, future work should examine whether the increased prevalence of Type II pattern observed in pathological gambling extends to substance addiction. Given the similarities between pathological gambling and substance addiction, especially in terms of OFC dysfunction62, one could expect a similarly skewed distribution of OFC sulcogyral patterns across the two disorders, in line with the idea of a general vulnerability factor that would predispose to addictive behaviors. However, recent work has also suggested that the neurobiology of pathological gambling and substance addiction might be more different than previously thought, in particular in terms of brain structure alterations3, and it could be that the present results are specific to pathological gambling. Ultimately, it will be crucial to design transdiagnostic studies jointly assessing structural and functional alterations in the OFC, in order to better understand how these two levels of alteration relate to each other and how much they generalize across disorders.

Supplementary information

supplemental material (31.9KB, docx)

Acknowledgements

Y.L. was supported by the National Natural Science Foundation of China (Grant No. 31600929) and the Fundamental Research Funds for the Central Universities (010914380002). G.S. was supported by a Veni grant from the Netherlands Organization for Scientific Research (Grant No. 016.155.218). J.J. was supported by the Academy of Finland (Grant No. 295580), the Finnish Medical Foundation, and the Finnish Foundation for Alcohol Studies. V.K. was supported by the Academy of Finland (Grant No. 256836) and the Finnish Foundation for Alcohol Studies. S.G. and H.R.S. were supported by the Danish Council for Independent Research in Social Sciences through a grant to Thomas Ramsøy (“Decision Neuroscience Project”; Grant No. 0601-01361B) and by the Lundbeck Foundation through a Grant of Excellence (“ContAct”; Grant No. R59 A5399). A.G. was supported by Deutsche Forschungsgemeinschaft (DFG) HE2597/15–1, HE2597/15–2, and DFG Graduiertenkolleg 1589/2 “Sensory Computation in Neural Systems”. N.R.-S. was supported by a research grant by the Senatsverwaltung für Gesundheit und Soziales, Berlin, Germany (Grant No. 002–2008/I B 35). C.M.R.d.L. and J.C.P. were supported by a grant from the Spanish Government (Ministerio de Economía y Competitividad, Secretaría de Estado de Investigación, Desarrollo e Innovación; Convocatoria 2017 de Proyectos I+D de Excelencia, Spain; co-funded by the Fondo Europeo de Desarrollo Regional, FEDER, European Union; Grant No. PSI2017–85488-P). J.-C.D. was supported by “LABEX ANR-11-LABEX-0042” of Université de Lyon within the program Investissements d’Avenir (ANR-11-IDEX-007) operated by the French National Research Agency and by a grant from the Fondation pour la Recherche Médicale (Grant No. DPA20140629796).

Author contributions

Y.L. and G.S. conceived and designed the study; Y.L. and Z.W. analyzed the data; Y.L., Z.W., and G.S. wrote the manuscript; I.B., J.-C.D., S.G., A.G., J.J., V.K., J.P., N.R.-S., C.M.R.d.L., H.R.S., R.J.v.H., and T.v.T. (listed alphabetically) edited the manuscript.

Conflict of interest

J.J. has received a research grant from the Orion Research Foundation and travel grants from Abbvie and Orion. V.K. reports a consultancy for Abbvie and honoraria/travel grants from Orion Pharma, Abbvie, Teva, GE Healthcare, NordicInfu Care AB, and Zambon. H.R.S. has received honoraria as speaker and scientific advisor from Sanofi Genzyme (Denmark), honoraria as senior editor of NeuroImage from Elsevier Publishers (Amsterdam, The Netherlands), royalties as book editor from Springer Publishers (Stuttgart), as well as a research fund from Biogen-idec. The other authors declare that they have no conflict of interest.

Footnotes

1

Here we prefer to employ the word “pathological gambling”, since all participants were recruited based on the diagnostic criteria of the DSM-IV, i.e. before it was renamed “gambling disorder”.

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Yansong Li, Zixiang Wang

Contributor Information

Yansong Li, Phone: +0086-025-89680958, Email: yansongli@nju.edu.cn.

Guillaume Sescousse, Phone: +0033 4 37 91 55 65, Email: guillaume.sescousse@inserm.fr.

Supplementary information

Supplementary Information accompanies this paper at (10.1038/s41398-019-0520-8).

References

  • 1.Bischof A, et al. Suicidal events among pathological gamblers: the role of comorbidity of axis I and axis II disorders. Psychiatry Res. 2015;225:413–419. doi: 10.1016/j.psychres.2014.11.074. [DOI] [PubMed] [Google Scholar]
  • 2.Insel T, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry. 2010;167:748–751. doi: 10.1176/appi.ajp.2010.09091379. [DOI] [PubMed] [Google Scholar]
  • 3.Clark, L., Boileau, I. & Zack, M. Neuroimaging of reward mechanisms in gambling disorder: an integrative review. Mol. Psychiatry24, 674–693 (2019). [DOI] [PubMed]
  • 4.Miedl SF, Peters J, Büchel C. Altered neural reward representations in pathological gamblers revealed by delay and probability discounting. Arch. Gen. Psychiatry. 2012;69:177–186. doi: 10.1001/archgenpsychiatry.2011.1552. [DOI] [PubMed] [Google Scholar]
  • 5.van Holst RJ, Veltman DJ, Büchel C, van den Brink W, Goudriaan AE. Distorted expectancy coding in problem gambling: is the addictive in the anticipation? Biol. Psychiatry. 2012;71:741–748. doi: 10.1016/j.biopsych.2011.12.030. [DOI] [PubMed] [Google Scholar]
  • 6.Balodis IM, et al. Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol. Psychiatry. 2012;71:749–757. doi: 10.1016/j.biopsych.2012.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Reuter J, et al. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat. Neurosci. 2005;8:147–148. doi: 10.1038/nn1378. [DOI] [PubMed] [Google Scholar]
  • 8.Sescousse G, Barbalat G, Domenech P, Dreher J-C. Imbalance in the sensitivity to different types of rewards in pathological gambling. Brain. 2013;136:2527–2538. doi: 10.1093/brain/awt126. [DOI] [PubMed] [Google Scholar]
  • 9.Brevers D, Noël X, He Q, Melrose JA, Bechara A. Increased ventral‐striatal activity during monetary decision making is a marker of problem poker gambling severity. Addict. Biol. 2016;21:688–699. doi: 10.1111/adb.12239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Power Y, Goodyear B, Crockford D. Neural correlates of pathological gamblers preference for immediate rewards during the Iowa gambling task: an fMRI study. J. Gambl. Stud. 2012;28:623–636. doi: 10.1007/s10899-011-9278-5. [DOI] [PubMed] [Google Scholar]
  • 11.Potenza MN, et al. An fMRI stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am. J. Psychiatry. 2003;160:1990–1994. doi: 10.1176/appi.ajp.160.11.1990. [DOI] [PubMed] [Google Scholar]
  • 12.Seghier ML, Price CJ. Interpreting and utilising intersubject variability in brain function. Trends Cogn. Sci. 2018;22:517–530. doi: 10.1016/j.tics.2018.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mohammadi B, et al. Intertemporal choice behavior is constrained by brain structure in healthy participants and pathological gamblers. Brain Struct. Funct. 2016;221:3157–3170. doi: 10.1007/s00429-015-1093-9. [DOI] [PubMed] [Google Scholar]
  • 14.Zois E, et al. Frontal cortex gray matter volume alterations in pathological gambling occur independently from substance use disorder. Addict. Biol. 2017;22:864–872. doi: 10.1111/adb.12368. [DOI] [PubMed] [Google Scholar]
  • 15.Ruiz de Lara CM, Navas JF, Soriano-Mas C, Sescousse G, Perales JC. Regional grey matter volume correlates of gambling disorder, gambling-related cognitive distortions, and emotion-driven impulsivity. Int. Gambl. Stud. 2018;18:195–216. doi: 10.1080/14459795.2018.1448427. [DOI] [Google Scholar]
  • 16.Grant JE, Odlaug BL, Chamberlain SR. Reduced cortical thickness in gambling disorder: a morphometric MRI study. Eur. Arch. Psychiatry Clin. Neurosci. 2015;265:655–661. doi: 10.1007/s00406-015-0592-2. [DOI] [PubMed] [Google Scholar]
  • 17.Fuentes D, et al. Mapping brain volumetric abnormalities in never-treated pathological gamblers. Psychiatry Res. 2015;232:208–213. doi: 10.1016/j.pscychresns.2015.04.001. [DOI] [PubMed] [Google Scholar]
  • 18.Joutsa J, Saunavaara J, Parkkola R, Niemelä S, Kaasinen V. Extensive abnormality of brain white matter integrity in pathological gambling. Psychiatry Res. 2011;194:340–346. doi: 10.1016/j.pscychresns.2011.08.001. [DOI] [PubMed] [Google Scholar]
  • 19.van Holst RJ, de Ruiter MB, van den Brink W, Veltman DJ, Goudriaan AE. A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. Drug Alcohol Depend. 2012;124:142–148. doi: 10.1016/j.drugalcdep.2011.12.025. [DOI] [PubMed] [Google Scholar]
  • 20.Yip SW, et al. Gray‐matter relationships to diagnostic and transdiagnostic features of drug and behavioral addictions. Addict. Biol. 2018;23:394–402. doi: 10.1111/adb.12492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Madan CR. Age differences in head motion and estimates of cortical morphology. PeerJ. 2018;6:e5176. doi: 10.7717/peerj.5176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Takeuchi H, et al. Common and differential brain abnormalities in gambling disorder subtypes based on risk attitude. Addict. Behav. 2017;69:48–54. doi: 10.1016/j.addbeh.2017.01.025. [DOI] [PubMed] [Google Scholar]
  • 23.Ersche KD, Williams GB, Robbins TW, Bullmore ET. Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience. Curr. Opin. Neurobiol. 2013;23:615–624. doi: 10.1016/j.conb.2013.02.017. [DOI] [PubMed] [Google Scholar]
  • 24.Fusar-Poli P, et al. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci. Biobehav. Rev. 2013;37:1680–1691. doi: 10.1016/j.neubiorev.2013.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lorenzetti V, Allen NB, Fornito A, Yücel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J. Affect. Disord. 2009;117:1–17. doi: 10.1016/j.jad.2008.11.021. [DOI] [PubMed] [Google Scholar]
  • 26.Armstrong E, Schleicher A, Omran H, Curtis M, Zilles K. The ontogeny of human gyrification. Cereb. Cortex. 1995;5:56–63. doi: 10.1093/cercor/5.1.56. [DOI] [PubMed] [Google Scholar]
  • 27.White T, Su S, Schmidt M, Kao C-Y, Sapiro G. The development of gyrification in childhood and adolescence. Brain Cogn. 2010;72:36–45. doi: 10.1016/j.bandc.2009.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Whittle S, et al. Orbitofrontal sulcogyral patterns are related to temperamental risk for psychopathology. Soc. Cogn. Affect. Neurosci. 2014;9:232–239. doi: 10.1093/scan/nss126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chiavaras MM, Petrides M. Orbitofrontal sulci of the human and macaque monkey brain. J. Comp. Neurol. 2000;422:35–54. doi: 10.1002/(SICI)1096-9861(20000619)422:1&#x0003c;35::AID-CNE3&#x0003e;3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  • 30.Li Y, Sescousse G, Amiez C, Dreher J-C. Local morphology predicts functional organization of experienced value signals in the human orbitofrontal cortex. J. Neurosci. 2015;35:1648–1658. doi: 10.1523/JNEUROSCI.3058-14.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Nakamura M, et al. Altered orbitofrontal sulcogyral pattern in schizophrenia. Brain. 2007;130:693–707. doi: 10.1093/brain/awm007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bartholomeusz CF, et al. Sulcogyral patterns and morphological abnormalities of the orbitofrontal cortex in psychosis. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2013;44:168–177. doi: 10.1016/j.pnpbp.2013.02.010. [DOI] [PubMed] [Google Scholar]
  • 33.Cropley VL, et al. Investigation of orbitofrontal sulcogyral pattern in chronic schizophrenia. Psychiatry Res. 2015;234:280–283. doi: 10.1016/j.pscychresns.2015.09.001. [DOI] [PubMed] [Google Scholar]
  • 34.Takayanagi Y, et al. Volume reduction and altered sulco-gyral pattern of the orbitofrontal cortex in first-episode schizophrenia. Schizophr. Res. 2010;121:55–65. doi: 10.1016/j.schres.2010.05.006. [DOI] [PubMed] [Google Scholar]
  • 35.Isomura S, et al. Altered sulcogyral patterns of orbitofrontal cortex in a large cohort of patients with schizophrenia. NPJ Schizophr. 2017;3:3. doi: 10.1038/s41537-016-0008-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Nishikawa Y, et al. Orbitofrontal sulcogyral pattern and olfactory sulcus depth in the schizophrenia spectrum. Eur. Arch. Psychiatry Clin. Neurosci. 2016;266:15–23. doi: 10.1007/s00406-015-0587-z. [DOI] [PubMed] [Google Scholar]
  • 37.Uehara-Aoyama K, et al. Sexually dimorphic distribution of orbitofrontal sulcogyral pattern in schizophrenia. Psychiatry Clin. Neurosci. 2011;65:483–489. doi: 10.1111/j.1440-1819.2011.02229.x. [DOI] [PubMed] [Google Scholar]
  • 38.Chakirova G, et al. Orbitofrontal morphology in people at high risk of developing schizophrenia. Eur. Psychiatry. 2010;25:366–372. doi: 10.1016/j.eurpsy.2010.03.001. [DOI] [PubMed] [Google Scholar]
  • 39.Lavoie S, et al. Sulcogyral pattern and sulcal count of the orbitofrontal cortex in individuals at ultra high risk for psychosis. Schizophr. Res. 2014;154:93–99. doi: 10.1016/j.schres.2014.02.008. [DOI] [PubMed] [Google Scholar]
  • 40.Nakamura Mihoko, Takahashi Tsutomu, Takayanagi Yoichiro, Sasabayashi Daiki, Katagiri Naoyuki, Sakuma Atsushi, Obara Chika, Koike Shinsuke, Yamasue Hidenori, Furuichi Atsushi, Kido Mikio, Nishikawa Yumiko, Noguchi Kyo, Matsumoto Kazunori, Mizuno Masafumi, Kasai Kiyoto, Suzuki Michio. Surface morphology of the orbitofrontal cortex in individuals at risk of psychosis: a multicenter study. European Archives of Psychiatry and Clinical Neuroscience. 2018;269(4):397–406. doi: 10.1007/s00406-018-0890-6. [DOI] [PubMed] [Google Scholar]
  • 41.Watanabe H, et al. Altered orbitofrontal sulcogyral patterns in adult males with high-functioning autism spectrum disorders. Soc. Cogn. Affect. Neurosci. 2014;9:520–528. doi: 10.1093/scan/nst016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Chye Y, et al. Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2017;79(Pt B):392–400. doi: 10.1016/j.pnpbp.2017.07.017. [DOI] [PubMed] [Google Scholar]
  • 43.Boileau I, et al. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11 C]-(+)-PHNO. Mol. Psychiatry. 2014;19:1305–1313. doi: 10.1038/mp.2013.163. [DOI] [PubMed] [Google Scholar]
  • 44.Gelskov SV, Madsen KH, Ramsøy TZ, Siebner HR. Aberrant neural signatures of decision-making: pathological gamblers display cortico-striatal hypersensitivity to extreme gambles. NeuroImage. 2016;128:342–352. doi: 10.1016/j.neuroimage.2016.01.002. [DOI] [PubMed] [Google Scholar]
  • 45.Romanczuk‐Seiferth N, Koehler S, Dreesen C, Wüstenberg T, Heinz A. Pathological gambling and alcohol dependence: neural disturbances in reward and loss avoidance processing. Addict. Biol. 2015;20:557–569. doi: 10.1111/adb.12144. [DOI] [PubMed] [Google Scholar]
  • 46.van Timmeren T, Jansen JM, Caan MWA, Goudriaan AE, Holst RJ. White matter integrity between left basal ganglia and left prefrontal cortex is compromised in gambling disorder. Addict. Biol. 2017;22:1590–1600. doi: 10.1111/adb.12447. [DOI] [PubMed] [Google Scholar]
  • 47.Sescousse G, et al. Amplified striatal responses to near-miss outcomes in pathological gamblers. Neuropsychopharmacology. 2016;41:2614–2623. doi: 10.1038/npp.2016.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Genauck, A. et al. Neural correlates of cue-induced changes in decision-making distinguish subjects with gambling disorder from healthy controls. BioRxiv10.1101/498725 (2018). [DOI] [PubMed]
  • 49.Lesieur H, Blume S. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am. J. Psychiatry. 1987;144:1184–1188. doi: 10.1176/ajp.144.9.1184. [DOI] [PubMed] [Google Scholar]
  • 50.Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS) J. Gambl. Stud. 2005;21:431–443. doi: 10.1007/s10899-005-5557-3. [DOI] [PubMed] [Google Scholar]
  • 51.Lorains FK, Cowlishaw S, Thomas SA. Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta‐analysis of population surveys. Addiction. 2011;106:490–498. doi: 10.1111/j.1360-0443.2010.03300.x. [DOI] [PubMed] [Google Scholar]
  • 52.Jamil T, et al. Default “Gunel and Dickey” Bayes factors for contingency tables. Behav. Res. Methods. 2017;49:638–652. doi: 10.3758/s13428-016-0739-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Cheetham A, et al. Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study. Biol. Psychiatry. 2012;71:684–692. doi: 10.1016/j.biopsych.2011.10.029. [DOI] [PubMed] [Google Scholar]
  • 54.Lotfipour S, et al. Orbitofrontal cortex and drug use during adolescence: role of prenatal exposure to maternal smoking and bdnf genotype. Arch. Gen. Psychiatry. 2009;66:1244–1252. doi: 10.1001/archgenpsychiatry.2009.124. [DOI] [PubMed] [Google Scholar]
  • 55.Kühn S, et al. From mother to child: orbitofrontal cortex gyrification and changes of drinking behaviour during adolescence. Addict. Biol. 2016;21:700–708. doi: 10.1111/adb.12240. [DOI] [PubMed] [Google Scholar]
  • 56.Thiebaut de Schotten M, Dell’Acqua F, Valabregue R, Catani M. Monkey to human comparative anatomy of the frontal lobe association tracts. Cortex. 2012;48:82–96. doi: 10.1016/j.cortex.2011.10.001. [DOI] [PubMed] [Google Scholar]
  • 57.Van Essen DC. A tension-based theory of morphogenesis and compact wiring in the central nervous system. Nature. 1997;385:313–318. doi: 10.1038/385313a0. [DOI] [PubMed] [Google Scholar]
  • 58.Zilles K, Palomero-Gallagher N, Amunts K. Development of cortical folding during evolution and ontogeny. Trends Neurosci. 2013;36:275–284. doi: 10.1016/j.tins.2013.01.006. [DOI] [PubMed] [Google Scholar]
  • 59.Mueller S, et al. Individual variability in functional connectivity architecture of the human brain. Neuron. 2013;77:586–595. doi: 10.1016/j.neuron.2012.12.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Zhang H, Harris L, Split M, Troiani V, Olson IR. Anhedonia and individual differences in orbitofrontal cortex sulcogyral morphology. Hum. Brain Mapp. 2016;37:3873–3881. doi: 10.1002/hbm.23282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Milosevic A, Ledgerwood DM. The subtyping of pathological gambling: a comprehensive review. Clin. Psychol. Rev. 2010;30:988–998. doi: 10.1016/j.cpr.2010.06.013. [DOI] [PubMed] [Google Scholar]
  • 62.Leeman RF, Potenza M. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology. 2012;219:469–490. doi: 10.1007/s00213-011-2550-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplemental material (31.9KB, docx)

Articles from Translational Psychiatry are provided here courtesy of Nature Publishing Group

RESOURCES